Cargando…

Evaluation of miR‐130 family members as circulating biomarkers for the diagnosis of bladder cancer

OBJECTIVE: Previous research has shown that the miR‐130 family is closely related to the occurrence and development of bladder cancer. We hope to use the miR‐130 family members as new, non‐invasive, and easily detectable biomarkers for bladder cancer. METHODS: We analyzed 428 cases in The Cancer Gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jingyao, Zhao, Liwen, Peng, Xiqi, Liu, Kaihao, Zhang, Chunduo, Chen, Xuan, Han, Yanni, Lai, Yongqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755799/ https://www.ncbi.nlm.nih.gov/pubmed/32761678 http://dx.doi.org/10.1002/jcla.23517

Ejemplares similares

Evaluation of Serum miR-17-92 Cluster as Noninvasive Biomarkers for Bladder Cancer Diagnosis
por: Wang, Jingyao, et al.
Publicado: (2021)

Identification of grade-related genes and construction of a robust genomic-clinicopathologic nomogram for predicting recurrence of bladder cancer
por: Peng, Xiqi, et al.
Publicado: (2020)

miR‐30b‐5p up‐regulation related to the dismal prognosis for patients with renal cell cancer
por: Zhang, Chunduo, et al.
Publicado: (2020)

Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis
por: Chen, Xuan, et al.
Publicado: (2020)

Use of a Four-miRNA Panel as a Biomarker for the Diagnosis of Stomach Adenocarcinoma
por: Chen, Xuan, et al.
Publicado: (2020)

Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test
por: Li, Rongkang, et al.
Publicado: (2022)

A panel of three serum microRNA can be used as potential diagnostic biomarkers for nasopharyngeal carcinoma
por: Li, Rongkang, et al.
Publicado: (2022)

miR-148 family members are putative biomarkers for sepsis
por: Dong, Lei, et al.
Publicado: (2019)

Clinical Significance of MiR-130b and MiR-125b as Biomarkers in Hepatocellular Carcinoma
por: El-Naidany, Sherin Sobhy, et al.
Publicado: (2022)

Circulating miR‐130b‐ and miR‐21‐based diagnostic markers and therapeutic targets for hepatocellular carcinoma
por: Zhang, Nannan, et al.
Publicado: (2019)

Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer
por: Du, Mulong, et al.
Publicado: (2015)

MiR-130a-3p suppresses colorectal cancer growth by targeting Wnt Family Member 1 (WNT1)
por: Song, Guang-Lin, et al.
Publicado: (2021)

The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN
por: Egawa, Hiroshi, et al.
Publicado: (2016)

Pan-Cancer Analysis of BUB1B/hsa-miR-130a-3p Axis and Identification of Circulating hsa-miR-130a-3p as a Potential Biomarker for Cancer Risk Assessment
por: Ding, Xiaoxia, et al.
Publicado: (2022)

Upregulation of circulating miR130a is correlated with development of Barrett’s esophagus and esophageal adenocarcinoma
por: Wang, Li, et al.
Publicado: (2018)

Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1
por: Monoe, Yuya, et al.
Publicado: (2021)

Elevated miR-130a/miR130b/miR-152 expression reduces intracellular ATP levels in the pancreatic beta cell
por: Ofori, Jones K., et al.
Publicado: (2017)

Circulating miR-130 is a potential bio signature for early prognosis of acute myocardial infarction
por: Pan, Xiaodong, et al.
Publicado: (2020)

MiR‐130b promotes the progression of oesophageal squamous cell carcinoma by targeting SASH1
por: Zhu, Yuxing, et al.
Publicado: (2018)

Members of the miR-30 family inhibit the epithelial-to-mesenchymal transition of non-small-cell lung cancer cells by suppressing XB130 expression levels
por: Song, Kewei, et al.
Publicado: (2020)

Identification of miR-320 family members as potential diagnostic and prognostic biomarkers in myelodysplastic syndromes
por: Wan, Chengyao, et al.
Publicado: (2021)

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study
por: Liu, Angela M, et al.
Publicado: (2012)

Circulating miR‐130 and its target PPAR‐γ may be potential biomarkers in patients of coronary artery disease with type 2 diabetes mellitus
por: Yuan, Yonggang, et al.
Publicado: (2019)

MiR-221 and miR-130a Regulate Lung Airway and Vascular Development
por: Mujahid, Sana, et al.
Publicado: (2013)

miR-130b duplex (miR-130b-3p/miR-130b-5p) negatively regulates goat intramuscular preadipocyte lipid droplets accumulation by inhibiting Krüppel-like factor 3 expression
por: Li, Yanyan, et al.
Publicado: (2023)

Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients
por: Stückrath, Isabel, et al.
Publicado: (2015)

Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer
por: Choi, Pui-Wah, et al.
Publicado: (2020)

miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma
por: Ivo D’Urso, Pietro, et al.
Publicado: (2015)

Chi-miR-130b-3p regulates Inner Mongolia cashmere goat skin hair follicles in fetuses by targeting Wnt family member 10A
por: Wu, Zhihong, et al.
Publicado: (2020)

Plasma Levels of miR-27a, miR-130b, and miR-301a in Polycystic Ovary Syndrome
por: Pourteymour Fard Tabrizi, Zahra, et al.
Publicado: (2020)

Circulating plasma and exosome levels of the miR-320 family as a non-invasive biomarker for methamphetamine use disorder
por: Xu, Wenjin, et al.
Publicado: (2023)

NRP1 is targeted by miR-130a and miR-130b, and is associated with multidrug resistance in epithelial ovarian cancer based on integrated gene network analysis
por: CHEN, CHANGXIAN, et al.
Publicado: (2016)

Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcoma
por: Taheriazam, Afshin, et al.
Publicado: (2015)

Circulating miR-20a and miR-26a as Biomarkers in Prostate Cancer
por: Torbati, Peyman Mohammadi, et al.
Publicado: (2019)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
por: Qiu, Shuwei, et al.
Publicado: (2013)

Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine
por: Lin, Jen-Tai, et al.
Publicado: (2021)

Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage Lung Adenocarcinoma
por: Han, Zhijun, et al.
Publicado: (2020)

Circulating miR-130a-3p is elevated in patients with cerebral atherosclerosis and predicts 2-year risk of cerebrovascular events
por: Xu, Jialei, et al.
Publicado: (2022)

Interleukin-18 and miR-130a in severe sepsis patients with thrombocytopenia
por: Cui, Yao-Li, et al.
Publicado: (2016)

Oncogenic role of MiR-130a in oral squamous cell carcinoma
por: Mallela, Karthik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_57d5a6ei3bhaejrma9fti0gbvc